MICHELLE WRIEDEN: Open Payments
NPI 1790475879 · DALE CITY, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,258 in 165 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $3,590 · 2025 $3,258
Food & beverage: $3,258
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $804 |
| Janssen Biotech, Inc. | 19 | $483 |
| QOL Medical, LLC | 8 | $220 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $217 |
| PFIZER INC. | 15 | $202 |
| Ardelyx, Inc. | 11 | $198 |
| GENZYME CORPORATION | 8 | $195 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $188 |
| Madrigal Pharmaceuticals | 5 | $188 |
| Gilead Sciences, Inc. | 5 | $102 |
Products named: RINVOQ, TREMFYA, DUPIXENT, Sucraid, IBSRELA, ENTYVIO, REZDIFFRA, XIFAXAN.
Industry payments across VA — which companies pay providers there.
